Clinical Trial Detail

NCT ID NCT02299141
Title Nintedanib in Molecularly Selected Patients With Advanced Non-Small Cell Lung Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Washington University School of Medicine
Indications

lung non-small cell carcinoma

Therapies

Nintedanib

Age Groups: adult senior

Additional content available in CKB BOOST